|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
SCIDIR_on1163957812 |
| 003 |
OCoLC |
| 005 |
20231120010500.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
200710s2020 enk o 001 0 eng d |
| 040 |
|
|
|a YDX
|b eng
|e pn
|c YDX
|d OPELS
|d EBLCP
|d OCLCF
|d UKMGB
|d OCLCO
|d OCLCQ
|d OCLCO
|d SFB
|d OCLCQ
|d CASUM
|d OCLCO
|
| 015 |
|
|
|a GBC0J1020
|2 bnb
|
| 016 |
7 |
|
|a 020003685
|2 Uk
|
| 019 |
|
|
|a 1163557094
|
| 020 |
|
|
|a 9780128209295
|q (electronic bk.)
|
| 020 |
|
|
|a 0128209291
|q (electronic bk.)
|
| 020 |
|
|
|z 9780128206799
|
| 020 |
|
|
|z 0128206799
|
| 035 |
|
|
|a (OCoLC)1163957812
|z (OCoLC)1163557094
|
| 050 |
|
4 |
|a RC280.H4
|
| 072 |
|
7 |
|a SCI
|x 086000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.99/49106
|2 23
|
| 245 |
0 |
0 |
|a Novel therapies in head and neck cancer :
|b beyond the horizon /
|c edited by Maie A. St. John and No-Hee Park.
|
| 260 |
|
|
|a London :
|b Academic Press,
|c 2020.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Cancer sensitizing agents for chemotherapy ;
|v v. 9
|
| 500 |
|
|
|a Includes index.
|
| 505 |
0 |
|
|a Intro -- Novel Therapies in Head and Neck Cancer: Beyond the Horizon -- Copyright -- Cover Image Legend -- Aims and scope for series ``Cancer sensitizing agents for chemotherapy�� -- About the Series Editor -- Aims and Scope of the Volume -- About the Volume Editors -- Maie A. St. John, M.D., Ph.D., FACS -- No-Hee Park, D.M.D., Ph.D. -- Preface -- It takes a village -- Contents -- Contributors -- Chapter 1: Introduction: Leaps and bounds -- Conflict of interest -- Introduction -- Surgical innovation: TORS and TLM -- Radiation therapy -- Immunotherapy -- Conclusion -- References
|
| 505 |
8 |
|
|a Chapter 2: Chemotherapy: Where we have been and where we are going -- Introduction -- Chemotherapy in locally advanced SCCHN -- Postoperative concurrent chemoradiotherapy -- Definitive combined chemoradiotherapy -- Definitive concurrent chemoradiotherapy (CCRT) -- Induction chemotherapy -- Sequential chemoradiotherapy -- Systemic therapy for recurrent, unresectable, or metastatic disease -- Nasopharyngeal cancer -- Conclusion -- References -- Chapter 3: Targeted therapy: Precision comes to life -- Introduction
|
| 505 |
8 |
|
|a Employing the precision medicine model for the management of head and neck squamous cell carcinoma -- Targeting the epidermal growth factor receptor -- Targeting the phosphoinositide 3-kinase-AKT-Mammalian target of rapamycin axis -- Single agent and combinatorial approaches to targeting the cell cycle pathway -- Precision medicine initiatives for the management of salivary gland carcinomas -- Leveraging the epigenetic and immunogenic role of histone deacetylase inhibitors -- Employing a multitargeted approach to tyrosine kinase inhibition -- Concluding remarks -- References
|
| 505 |
8 |
|
|a Chapter 4: Novel drug delivery systems for head and neck cancers: Beyond the horizon -- Introduction -- Polymer films -- Hydrogels and scaffolds -- Augmented radiation therapy and imaging -- Microneedle patches -- Nanoparticles -- Immunomodulation -- Conclusion -- Acknowledgments -- References -- Chapter 5: HPV-positive oropharyngeal cancers: Today and tomorrow -- Introduction -- Epidemiology -- Current staging -- Treatment options and outcomes -- Nonsurgical treatment options -- Radiation therapy -- Systemic therapy with radiation therapy -- Surgical treatment options
|
| 505 |
8 |
|
|a Transoral robotic surgery (TORS) -- Current status of deescalation strategies -- Minimally invasive surgery -- Replacing cisplatin with cetuximab -- Induction chemotherapy followed by reduced radiotherapy dose -- Immunotherapy -- Preventive strategies -- Ongoing and future research -- Conclusions -- References -- Chapter 6: Treatment resistance and a glimmer of hope, the promise of new agents -- Introduction -- Treatment resistance: Defining the problem -- Treatment resistance: Detecting the problem -- Biology is destiny -- Radiation resistance
|
| 650 |
|
0 |
|a Head
|x Cancer
|x Treatment.
|
| 650 |
|
0 |
|a Neck
|x Cancer
|x Treatment.
|
| 650 |
|
2 |
|a Head and Neck Neoplasms
|x therapy
|0 (DNLM)D006258Q000628
|
| 650 |
|
7 |
|a Head
|x Cancer
|x Treatment
|2 fast
|0 (OCoLC)fst00952589
|
| 650 |
|
7 |
|a Neck
|x Cancer
|x Treatment
|2 fast
|0 (OCoLC)fst01035351
|
| 655 |
|
4 |
|a Internet Resources.
|
| 700 |
1 |
|
|a St. John, Maie A.
|
| 700 |
1 |
|
|a Park, No-Hee.
|
| 776 |
0 |
8 |
|i Print version:
|t Novel therapies in head and neck cancer.
|d London : Academic Press, 2020
|z 0128206799
|z 9780128206799
|w (OCoLC)1135669832
|
| 830 |
|
0 |
|a Cancer sensitizing agents for chemotherapy ;
|v v. 9.
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128206799
|z Texto completo
|
